227 related articles for article (PubMed ID: 16052638)
1. Alzheimer's disease related copper(II)- beta-amyloid peptide exhibits phenol monooxygenase and catechol oxidase activities.
da Silva GF; Ming LJ
Angew Chem Int Ed Engl; 2005 Aug; 44(34):5501-4. PubMed ID: 16052638
[No Abstract] [Full Text] [Related]
2. Role of aspartate-1 in Cu(II) binding to the amyloid-beta peptide of Alzheimer's disease.
Karr JW; Szalai VA
J Am Chem Soc; 2007 Apr; 129(13):3796-7. PubMed ID: 17352478
[No Abstract] [Full Text] [Related]
3. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
Tõugu V; Karafin A; Palumaa P
J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
Han D; Wang H; Yang P
Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
Jiao Y; Yang P
J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
[TBL] [Abstract][Full Text] [Related]
6. CU(II)-catalyzed oxidation of Alzheimer's disease beta-amyloid peptide and related sequences: remarkably different selectivities of neurotoxic betaAP1-40 and non-toxic betaAP40-1.
Schöneich C; Williams TD
Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):753-61. PubMed ID: 14528912
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into dioxygen-activating copper enzymes.
Rosenzweig AC; Sazinsky MH
Curr Opin Struct Biol; 2006 Dec; 16(6):729-35. PubMed ID: 17011183
[TBL] [Abstract][Full Text] [Related]
8. Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.
Haeffner F; Smith DG; Barnham KJ; Bush AI
J Inorg Biochem; 2005 Dec; 99(12):2403-22. PubMed ID: 16271394
[TBL] [Abstract][Full Text] [Related]
9. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
[TBL] [Abstract][Full Text] [Related]
10. The chemistry of Alzheimer's disease.
Rauk A
Chem Soc Rev; 2009 Sep; 38(9):2698-715. PubMed ID: 19690748
[TBL] [Abstract][Full Text] [Related]
11. Metallo-ROS in Alzheimer's disease: oxidation of neurotransmitters by CuII-beta-amyloid and neuropathology of the disease.
da Silva GF; Ming LJ
Angew Chem Int Ed Engl; 2007; 46(18):3337-41. PubMed ID: 17378003
[No Abstract] [Full Text] [Related]
12. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
[TBL] [Abstract][Full Text] [Related]
13. The Cu(II) complex of Abeta40 peptide in ammonium acetate solutions. Evidence for ternary species formation.
Rózga M; Protas AM; Jabłonowska A; Dadlez M; Bal W
Chem Commun (Camb); 2009 Mar; (11):1374-6. PubMed ID: 19259592
[TBL] [Abstract][Full Text] [Related]
14. Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.
Streltsov VA; Varghese JN
Chem Commun (Camb); 2008 Jul; (27):3169-71. PubMed ID: 18594731
[TBL] [Abstract][Full Text] [Related]
15. The influence of catechol structure on the suicide-inactivation of tyrosinase.
Ramsden CA; Stratford MR; Riley PA
Org Biomol Chem; 2009 Sep; 7(17):3388-90. PubMed ID: 19675891
[TBL] [Abstract][Full Text] [Related]
16. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
Sultana R; Perluigi M; Butterfield DA
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
[TBL] [Abstract][Full Text] [Related]
17. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
[TBL] [Abstract][Full Text] [Related]
18. High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide.
Danielsson J; Pierattelli R; Banci L; Gräslund A
FEBS J; 2007 Jan; 274(1):46-59. PubMed ID: 17222176
[TBL] [Abstract][Full Text] [Related]
19. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
Faller P; Hureau C
Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.
Drew SC; Noble CJ; Masters CL; Hanson GR; Barnham KJ
J Am Chem Soc; 2009 Jan; 131(3):1195-207. PubMed ID: 19119811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
